NCT04999163 - Aortix Therapy for Perioperative Reduction of Kidney Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 17, 2022

Primary Completion Date

August 22, 2023

Study Completion Date

August 22, 2023

Conditions

Acute Kidney Injury

Interventions

DEVICE

Aortix System

Aortix is indicated as a partial circulatory support device to increase renal perfusion and reduce the incidence of acute kidney injury (AKI) in patients undergoing cardiac surgery who are at heightened risk of developing AKI.

Trial Locations (5)

Unknown

Royal Adelaide Hospital, Adelaide

Prince Charles Hospital, Brisbane

Princess Alexandra Hospital, Brisbane

Monash Health, Melbourne

Macquarie University, Sydney